SPARC — Sun Pharma Advanced Research Share News
0.000.00%
Last trade - 00:00- IN₹55.74bn
- IN₹61.31bn
- IN₹391.48m
India's Sun Pharma Research up after Rekha Jhunjhunwala picks up stake
Brief: Sun Pharma Advanced Research Says SEZABY Approved By Us FDA
Brief: Sparc And Sun Pharma Enter Into License Agreement For Commercialization Of Phenobarbital
India's Sun Pharma Advanced Research jumps most in over 3 months
Brief: Sun Pharma Advanced Research Seeks Shareholders' Nod To Raise Funds Up To 18 Bln Rupees
India's Sun Pharma Advanced Research jumps on license deal
Brief: Sun Pharma Advanced Research Enters Into Licensing Agreement With Biomodifying
Brief: Sun Pharma Advanced Research - Approved Seeking Nod From Shareholders To Raise Funds
Brief: Sun Pharma Advanced Research Announces Positive Results From Phase 3 Trial For Glaucoma Treatment
Brief: FDA Denies Sun Pharma Advanced Research's Appeal of Complete Response Letter For Taclantis
Brief: India's SPARC Licenses Commercialization Rights Of Epilepsy Drug To Tripoint Therapeutics
Sun Pharma Advanced Research hits near 6-month high on June-qtr profit
Brief: Sun Pharmaceutical Industries Says Co, SPARC Enter Worldwide License Agreement For SCD-044
India's Sun Pharma Advanced falls as FDA declines approval to cancer treatment
Brief: Sun Pharma Advanced Research Company Gets Complete Response Letter From U.S. FDA
Brief: Sun Pharma Advanced Research Company Enters Agreement With Bioprojet To Buy Exclusive Rights For Investigational Medicinal Product SCD-044
Sun Pharma Advanced Research Co rises after patent infringement complaint is withdrawn
Brief: Sun Pharma Advanced Research Says Abraxis Biosciences Dismissed Patent Infringement Complaint Filed Against Co
Brief: India's Sun Pharma Advanced Research Company Sept Quarter Loss Widens